Press Release: Opella reaches study milestone for Cialis
Opella reaches study milestone for CialisParis, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and ...
Hosted on MSN26d
Have the New Pulmonary Hypertension Drugs Changed the Game?
The phase III A DUE trial showed significantly greater pulmonary vascular resistance improvements with the fixed-dose combination over macitentan (Opsumit) or tadalafil (Adcirca) monotherapy.
AOL25d
Cialis Side Effects: What to Expect (& How to Avoid Them)
Tadalafil 20-milligram side effects are often ... under the brand name Adcirca®. And it’s sometimes prescribed for pulmonary arterial hypertension (PAH), a form of high blood pressure affecting ...
NationofChange9d
FTC report exposes big pharma middlemen inflating drug prices by up to 7,736%
Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...